521 related articles for article (PubMed ID: 15547759)
1. Response of T and B lymphocytes in the spleen, lymph nodes and mammary tumors in rats treated with human soluble tumor-associated antigens and commercial human albumin.
Ben-Hur H; Kossoy G; Mehrdad H; Elhayany A; Zusman I
Oncol Rep; 2004 Dec; 12(6):1329-33. PubMed ID: 15547759
[TBL] [Abstract][Full Text] [Related]
2. Response of T- and B-lymphocytes in the spleen of mammary tumor-bearing rats to treatment with tamoxifen and soluble tumor-associated antigens.
Ben-Hur H; Kossoy G; Sanko H; Geva D; Shumlin N; Zusman I; Elhayany A
Oncol Rep; 2004 Jul; 12(1):181-5. PubMed ID: 15201981
[TBL] [Abstract][Full Text] [Related]
3. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors.
Ben-Hur H; Kossoy G; Zandbank J; Zusman I
Int J Mol Med; 2002 Apr; 9(4):425-30. PubMed ID: 11891540
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclophosphamide and soluble tumor-associated antigens on lymphoid infiltration, proliferative activity and rate of apoptosis in chemically-induced rat mammary tumors.
Ben-Hur H; Kossoy G; Tendler Y; Kossoy N; Zusman I
In Vivo; 2002; 16(5):287-92. PubMed ID: 12494865
[TBL] [Abstract][Full Text] [Related]
5. Human soluble tumor-associated antigens promote the suppression of rat mammary tumors by 5-fluorouracil and stimulate the functional activity of immune organs: Experimental and morphological studies.
Kossoy G; Ben-Hur H; Avinoach I; Alhayany A; Shneider DF; Zusman I
Int J Mol Med; 2003 Nov; 12(5):797-801. PubMed ID: 14533012
[TBL] [Abstract][Full Text] [Related]
6. Cytological aspects of rat mammary cancer therapy with soluble tumor-associated antigens and anticancer drugs.
Zusman I
Med Sci Monit; 2005 May; 11(5):RA173-181. PubMed ID: 15874908
[TBL] [Abstract][Full Text] [Related]
7. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular mass tumor-associated antigens: the spleen and lymph nodes.
Ben-Hur H; Kossoy G; Schneider DF; Zandbank J; Zusman I
Int J Mol Med; 2002 Mar; 9(3):311-6. PubMed ID: 11836638
[TBL] [Abstract][Full Text] [Related]
8. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
[TBL] [Abstract][Full Text] [Related]
9. Human soluble p66 and p51 tumor-associated antigens promote the suppression of rat mammary tumors in comparison to commercial human albumin.
Kossoy G; Avinoach I; Zusman I; Scheider DP; Ben-Hur H; Elhayany A
Oncol Rep; 2004 Feb; 11(2):487-91. PubMed ID: 14719088
[TBL] [Abstract][Full Text] [Related]
10. Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies.
Ben-Hur H; Gurevich P; Zion H; Berman V; Tendler Y; Sandler B; Zinder O; Zusman I
Anticancer Res; 1998; 18(1A):273-81. PubMed ID: 9568090
[TBL] [Abstract][Full Text] [Related]
11. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: the bone marrow and thymus.
Ben-Hur H; Kossoy G; Kossoy N; Zusman I
Int J Mol Med; 2002 Oct; 10(4):517-21. PubMed ID: 12239604
[TBL] [Abstract][Full Text] [Related]
12. Effects of the soluble low-molecular-mass proteins on spleen activity and cellular composition of infiltrates in rat mammary gland tumors.
Kossoy G; Ben-Hur H; Kossoy N; Zusman I
Int J Mol Med; 2001 Feb; 7(2):221-4. PubMed ID: 11172629
[TBL] [Abstract][Full Text] [Related]
13. T cell kinetics and apoptosis in immune organs and mammary tumors of rats treated with cyclophosphamide and soluble tumor-associated antigens.
Zusman I; Kossoy G; Ben-Hur H
In Vivo; 2002; 16(6):567-76. PubMed ID: 12494902
[TBL] [Abstract][Full Text] [Related]
14. Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.
Ben-Hur H; Ben-Meir A; Hagay Z; Ben-Meir A; Berman V; Schwartsburd B; Gurevich P; Sandler B; Tendler Y; Zinder O; Zusman I
Anticancer Res; 1998; 18(6A):4237-41. PubMed ID: 9891473
[TBL] [Abstract][Full Text] [Related]
15. Rat soluble tumor-associated antigens inhibit chemically-induced mammary tumorigenesis in syngeneic rats.
Kossoy G; Ben-Hur H; Elhayany A; Schneider DF; Zusman I
Oncol Rep; 2005 Apr; 13(4):585-8. PubMed ID: 15756427
[TBL] [Abstract][Full Text] [Related]
16. Profile of immune cells in lymph nodes draining human malignant tumors.
Di Girolamo W; Coronato S; Portiansky E; Laguens G
Medicina (B Aires); 2008; 68(6):423-7. PubMed ID: 19147422
[TBL] [Abstract][Full Text] [Related]
17. Studies on T and B lymphocytes in rats bearing methylcholanthrene-induced tumor.
Klobusická M; Kalafut F; Novotná L
Neoplasma; 1978; 25(6):667-77. PubMed ID: 313020
[TBL] [Abstract][Full Text] [Related]
18. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
19. Migration pathways of recirculating murine B cells and CD4+ and CD8+ T lymphocytes.
Pellas TC; Weiss L
Am J Anat; 1990 Apr; 187(4):355-73. PubMed ID: 2141229
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy, chemically-induced mammary tumors and parathymic lymph nodes in rats: experimental and morphological studies.
Ben-Hur H; Kossoy G; Lifschitz O; Zusman I
In Vivo; 2002; 16(4):275-80. PubMed ID: 12224138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
